Last reviewed · How we verify

NCT02851147

Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment

Completed Last updated 6 June 2022
What this trial tests

trial testing SL-D301 in Ocular Images in 30 participants. Completed in 1 June 2016.

Timeline
1 May 2016
Primary endpoint
1 May 2016
1 June 2016

Quick facts

Lead sponsorTopcon Medical Systems, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date1 May 2016
Primary completion1 May 2016
Estimated completion1 June 2016
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Topcon Medical Systems, Inc.

Who can join

18 and older, any sex, with Ocular Images. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of the evaluation is to confirm operability and usability of the SL-D301 Slit Lamp and the DC-4 digital camera attachment by conducting a usability evaluation and subsequently submitting a questionnaire and hold an interview with the operator. Of special interest for the study is to confirm whether the illumination level of SL-D301 is enough to perform an eye exam since the maximum illumination level on the SL-D301 is lower than other existing Topcon digital ready slit lamps due to regulations that limit the maximum light intensity on the human eye. The SL-D301 will be compared against the predicate device SL-3G.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Topcon Medical Systems, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02851147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing